十二年的探索：成纤维细胞生长因子 21 的生理学和药理学研究进展
A Dozen Years of Discovery: Insights into the Physiology and Pharmacology of FGF21.
机构信息
Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX 75390, USA; Department of Molecular Biology, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX 75390, USA; Howard Hughes Medical Institute, UT Southwestern Medical Center, Dallas, TX 75390, USA.
出版信息
Cell Metab. 2019 Feb 5;29(2):246-253. doi: 10.1016/j.cmet.2019.01.004.
Abstract
It has been more than a dozen years since FGF21 burst on the metabolism field in a paper showing that its pharmacologic administration caused weight loss and improved insulin sensitivity and lipoprotein profiles in obese rodents. Since then, FGF21 analogs have advanced all the way to clinical trials, and much progress has been made in understanding FGF21's pharmacology and physiology. In this Perspective, we highlight some of the interesting themes that have emerged from this first dozen years of FGF21 research, including its roles in autocrine/paracrine and endocrine responses to metabolic stress.
摘要
自 FGF21 在一篇论文中横空出世以来，已经过去了十多个年头，该论文表明其药物治疗可导致肥胖啮齿动物体重减轻，并改善胰岛素敏感性和脂蛋白谱。从那时起，FGF21 类似物一路推进到临床试验，并且在理解 FGF21 的药理学和生理学方面取得了很大进展。在本观点中，我们强调了从 FGF21 研究的最初十二年中出现的一些有趣主题，包括其在代谢应激的自分泌/旁分泌和内分泌反应中的作用。
相似文献
1
A Dozen Years of Discovery: Insights into the Physiology and Pharmacology of FGF21.十二年的探索：成纤维细胞生长因子 21 的生理学和药理学研究进展
Cell Metab. 2019 Feb 5;29(2):246-253. doi: 10.1016/j.cmet.2019.01.004.
2
Fibroblast growth factor 21: from pharmacology to physiology.成纤维细胞生长因子 21：从药理学到生理学。
Am J Clin Nutr. 2010 Jan;91(1):254S-257S. doi: 10.3945/ajcn.2009.28449B. Epub 2009 Nov 11.
3
Fibroblast Growth Factor 21 (FGF21) Administration Sex-Specifically Affects Blood Insulin Levels and Liver Steatosis in Obese Mice.成纤维细胞生长因子 21（FGF21）给药在肥胖小鼠中具有性别特异性，影响血液胰岛素水平和肝脏脂肪变性。
Cells. 2021 Dec 7;10(12):3440. doi: 10.3390/cells10123440.
4
FGF21 decreases body weight without reducing food intake or bone mineral density in high-fat fed obese rhesus macaque monkeys.成纤维细胞生长因子 21（FGF21）可降低高脂肪饮食肥胖恒河猴的体重，而不减少食物摄入量或降低骨矿物质密度。
Int J Obes (Lond). 2018 Jun;42(6):1151-1160. doi: 10.1038/s41366-018-0080-7. Epub 2018 Jun 11.
5
Multiple roles of fibroblast growth factor 21 in metabolism.成纤维细胞生长因子21在代谢中的多重作用。
Curr Pharm Des. 2015;21(21):3041-50. doi: 10.2174/1381612821666150212155239.
6
[THE ROLE OF FIBROBLAST GROWTH FACTOR 21 (FGF21) IN THE REGULATION AND CORRECTION OF CARBOHYDRATE AND LIPID METABOLISM].[成纤维细胞生长因子21（FGF21）在碳水化合物和脂质代谢调节与纠正中的作用]
Ross Fiziol Zh Im I M Sechenova. 2016 Dec;102(12):1406-16.
7
Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology.成纤维细胞生长因子 21：从药理学到生理学的新型代谢调节剂。
Front Med. 2013 Mar;7(1):25-30. doi: 10.1007/s11684-013-0244-8. Epub 2013 Jan 28.
8
Pharmacokinetics (PK), pharmacodynamics (PD) and integrated PK/PD modeling of a novel long acting FGF21 clinical candidate PF-05231023 in diet-induced obese and leptin-deficient obese mice.新型长效成纤维细胞生长因子21临床候选药物PF-05231023在饮食诱导肥胖和瘦素缺乏肥胖小鼠中的药代动力学（PK）、药效学（PD）及PK/PD整合模型
PLoS One. 2015 Mar 19;10(3):e0119104. doi: 10.1371/journal.pone.0119104. eCollection 2015.
9
Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.成纤维细胞生长因子21可逆转饮食诱导的肥胖小鼠的肝脂肪变性，增加能量消耗，并改善胰岛素敏感性。
Diabetes. 2009 Jan;58(1):250-9. doi: 10.2337/db08-0392. Epub 2008 Oct 7.
10
Pharmacological FGF21 signals to glutamatergic neurons to enhance leptin action and lower body weight during obesity.药理 FGFR21 信号传递至谷氨酸能神经元，在肥胖期间增强瘦素作用并降低体重。
Mol Metab. 2022 Oct;64:101564. doi: 10.1016/j.molmet.2022.101564. Epub 2022 Aug 6.
引用本文的文献
1
Dysregulation of the FGF21-Adiponectin Axis in a Large Cohort of Patients with Severe Obesity and Liver Disease.大量重度肥胖和肝病患者队列中FGF21-脂联素轴的失调
Int J Mol Sci. 2025 Sep 2;26(17):8510. doi: 10.3390/ijms26178510.
2
Different association of GDF15 and FGF21 with glycemic status and aging in the context of obesity.在肥胖背景下，生长分化因子15（GDF15）和成纤维细胞生长因子21（FGF21）与血糖状态及衰老的不同关联。
Geroscience. 2025 Aug 19. doi: 10.1007/s11357-025-01830-3.
3
Pathogenesis and Clinical Management of Metabolic Dysfunction-Associated Steatotic Liver Disease.代谢功能障碍相关脂肪性肝病的发病机制与临床管理
Int J Mol Sci. 2025 Jun 14;26(12):5717. doi: 10.3390/ijms26125717.
4
FGF21 promotes longevity in diet-induced obesity through metabolic benefits independent of growth suppression.成纤维细胞生长因子21（FGF21）通过独立于生长抑制的代谢益处促进饮食诱导肥胖中的长寿。
Cell Metab. 2025 Jul 1;37(7):1547-1567.e6. doi: 10.1016/j.cmet.2025.05.011. Epub 2025 Jun 16.
5
A systematic review and meta-analysis of efruxifermin's efficacy in improving liver fibrosis in patients with NASH/MASH.一项关于艾弗西费明改善非酒精性脂肪性肝炎/代谢相关脂肪性肝炎患者肝纤维化疗效的系统评价和荟萃分析。
Front Pharmacol. 2025 May 30;16:1594091. doi: 10.3389/fphar.2025.1594091. eCollection 2025.
6
Cysteine depletion triggers adipose tissue thermogenesis and weight loss.半胱氨酸耗竭引发脂肪组织产热和体重减轻。
Nat Metab. 2025 Jun 3. doi: 10.1038/s42255-025-01297-8.
7
Geranylgeranyl Pyrophosphate Promotes Hepatic Lipid Accumulation by Prenylation of Perilipin4.香叶基香叶基焦磷酸通过对脂滴包被蛋白4进行异戊二烯化修饰促进肝脏脂质积累。
Cell Mol Gastroenterol Hepatol. 2025 May 29;19(9):101546. doi: 10.1016/j.jcmgh.2025.101546.
8
Differential effects of bariatric surgery on circulating GDF15 and FGF21 levels: Implications for glycemic status and weight loss outcomes.减肥手术对循环中生长分化因子15（GDF15）和成纤维细胞生长因子21（FGF21）水平的不同影响：对血糖状态和体重减轻结果的影响。
Eur J Clin Invest. 2025 Oct;55(10):e70069. doi: 10.1111/eci.70069. Epub 2025 May 16.
9
Hepatokine and Proinflammatory Cytokine Profile in Patients with Carotid Atherosclerosis and Metabolic Dysfunction-Associated Steatotic Liver Disease.颈动脉粥样硬化和代谢功能障碍相关脂肪性肝病患者的肝源细胞因子和促炎细胞因子谱
Biomedicines. 2025 Apr 16;13(4):978. doi: 10.3390/biomedicines13040978.
10
Development of an iridium complex fluorescent probe for FGF21 protein labeling and tracking.用于FGF21蛋白标记和追踪的铱配合物荧光探针的研发。
Sci Rep. 2025 Apr 10;15(1):12365. doi: 10.1038/s41598-025-97470-w.
本文引用的文献
1
Ageing-related receptors resolved.与衰老相关的受体得到了解析。
Nature. 2018 Jan;553(7689):409-410. doi: 10.1038/d41586-017-09032-4.
2
Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial.培格非格司亭（BMS-986036），一种聚乙二醇化成纤维细胞生长因子 21 类似物，在非酒精性脂肪性肝炎患者中的应用：一项随机、双盲、安慰剂对照、2a 期临床试验。
Lancet. 2019 Dec 22;392(10165):2705-2717. doi: 10.1016/S0140-6736(18)31785-9. Epub 2018 Dec 13.
3
Pegbelfermin (BMS-986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study.培格非格司亭（BMS-986036），聚乙二醇化 FGF21，在肥胖症和 2 型糖尿病患者中的应用：一项随机 2 期研究结果。
Obesity (Silver Spring). 2019 Jan;27(1):41-49. doi: 10.1002/oby.22344. Epub 2018 Dec 6.
4
PPARγ-K107 SUMOylation regulates insulin sensitivity but not adiposity in mice.PPARγ-K107 SUMOylation 调节小鼠的胰岛素敏感性但不影响其肥胖程度。
Proc Natl Acad Sci U S A. 2018 Nov 27;115(48):12102-12111. doi: 10.1073/pnas.1814522115. Epub 2018 Nov 12.
5
FGF21 increases water intake, urine output and blood pressure in rats.成纤维细胞生长因子 21 可增加大鼠的饮水量、尿量和血压。
PLoS One. 2018 Aug 14;13(8):e0202182. doi: 10.1371/journal.pone.0202182. eCollection 2018.
6
A Receptor Activation Attenuates Hypertensive Cardiac Remodeling via Promoting Brown Adipose Tissue-Derived FGF21.一种受体的激活通过促进棕色脂肪组织来源的成纤维细胞生长因子 21 来减轻高血压性心脏重构。
Cell Metab. 2018 Sep 4;28(3):476-489.e5. doi: 10.1016/j.cmet.2018.06.013. Epub 2018 Jul 12.
7
Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis.成纤维细胞生长因子 21：代谢稳态的多功能调节剂。
Annu Rev Nutr. 2018 Aug 21;38:173-196. doi: 10.1146/annurev-nutr-071816-064800. Epub 2018 May 4.
8
The Hormone FGF21 Stimulates Water Drinking in Response to Ketogenic Diet and Alcohol.激素 FGF21 可响应生酮饮食和酒精刺激饮水。
Cell Metab. 2018 Jun 5;27(6):1338-1347.e4. doi: 10.1016/j.cmet.2018.04.001. Epub 2018 Apr 12.
9
FGF21, a liver hormone that inhibits alcohol intake in mice, increases in human circulation after acute alcohol ingestion and sustained binge drinking at Oktoberfest.成纤维细胞生长因子 21（FGF21）是一种肝脏激素，可抑制小鼠的饮酒量。在急性酒精摄入后以及在啤酒节期间持续狂饮期间，其在人体循环中增加。
Mol Metab. 2018 May;11:96-103. doi: 10.1016/j.molmet.2018.03.010. Epub 2018 Mar 27.
10
Structures of β-klotho reveal a 'zip code'-like mechanism for endocrine FGF signalling.β-klotho 结构揭示了内分泌 FGF 信号的“邮政编码”样机制。
Nature. 2018 Jan 25;553(7689):501-505. doi: 10.1038/nature25010. Epub 2018 Jan 17.
Zotero 插件